Replies to post #227896 on Biotech Values

[DewDiligence]

ITCI +66% on phase-3 data in bipolar disorder:

http://www.globenewswire.com/news-release/2020/09/09/2090748/0/en/Intra-Cellular-Therapies-Announces-Positive-Topline-Results-from-Study-402-Evaluating-Lumateperone-as-Adjunctive-Therapy-in-Patients-with-Bipolar-Depression.html